CervoMed Inc. (CRVO)
NASDAQ: CRVO
· Real-Time Price · USD
10.17
-0.02 (-0.20%)
At close: Aug 15, 2025, 3:59 PM
10.11
-0.59%
After-hours: Aug 15, 2025, 05:20 PM EDT
CervoMed Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 7.78M | 9.31M | 9.74M | 10.07M | 9.65M | 6.36M | 5.42M | 2.93M | 1.41M | 1.41M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 17.05M | 25.09M | 23.07M | 18.84M | 15.51M | 7.46M | 6.48M | 4M | 2.54M | 2.54M | 1.08M | 725.07K | 413.63K | 413.63K | 45.21K | 19.1K | n/a | n/a |
Gross Profit | -11.03M | -7.74M | -5.29M | -728.35K | 2.19M | -1.1M | -1.05M | -1.07M | -1.14M | -1.14M | -712K | -357.11K | -45.21K | -45.21K | -45.21K | -19.1K | n/a | n/a |
Operating Income | -24.56M | -20.93M | -18.23M | -13.47M | -10.74M | -10.04M | -11.71M | -13.48M | -13.73M | -15.68M | -15.97M | -15.19M | -16.32M | -15.91M | -16.04M | -16.66M | -17.88M | -17.7M |
Interest Income | 1.96M | 2.27M | 1.94M | 1.52M | 925.39K | 264.66K | 219.43K | 273.63K | 247.49K | 285.16K | 277.56K | 104.71K | 133.9K | 133.75K | 146.35K | 171.37K | 149.89K | 120.57K |
Pretax Income | -22.61M | -18.67M | -16.29M | -11.95M | -5.04M | -4.84M | -6.42M | -8.13M | -13.08M | -15.16M | -15.59M | -14.99M | -24.84M | -24.42M | -24.54M | -25.13M | -17.73M | -17.58M |
Net Income | -22.61M | -18.67M | -16.29M | -11.95M | -5.04M | -4.84M | -6.42M | -8.13M | -11.16M | -13.24M | -13.68M | -13.08M | -24.39M | -23.98M | -24.1M | -24.68M | -16.92M | -16.27M |
Selling & General & Admin | 10.18M | 9.42M | 9.17M | 8.97M | 9.17M | 8.87M | 7.75M | 7.97M | 7.69M | 7.61M | 8.73M | 8.33M | 8.13M | 7.83M | 7.45M | 6.99M | 7.17M | 6.79M |
Research & Development | 22.16M | 20.82M | 18.8M | 14.57M | 11.23M | 7.53M | 6.03M | 5.08M | 4.08M | 6.12M | 7.24M | 6.84M | 8.15M | 8.01M | 8.5M | 9.58M | 10.61M | 10.81M |
Other Expenses | -17.05M | -17.05M | -15.03M | -10.79M | -7.46M | -7.46M | -3.79M | -934.3K | 856.58K | 856.58K | n/a | 26.11K | 26.11K | 49.87K | 74.32K | 73.14K | 97.33K | 100.59K |
Operating Expenses | 15.28M | 13.19M | 12.94M | 12.74M | 12.94M | 8.95M | 11.08M | 13.22M | 13.73M | 15.68M | 15.97M | 15.16M | 16.28M | 15.86M | 15.99M | 16.64M | 17.88M | 17.7M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.79M | 3.34M | 3.34M | 3.34M | 1.55M | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 32.33M | 30.24M | 27.97M | 23.53M | 20.4M | 16.41M | 15.73M | 15.01M | 13.73M | 15.68M | 15.97M | 15.19M | 16.32M | 15.91M | 16.04M | 16.66M | 17.88M | 17.7M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -904K | -904K | -904K | -904K | -444K | -444K | -444K | -444K | -806K | -1.31M |
Shares Outstanding (Basic) | 8.95M | 8.7M | 8.7M | 8.7M | 8.7M | 6.17M | 5.67M | 3.31M | 1.36M | 1.36M | 1.36M | 1.36M | 1.36M | 1.36M | 1.36M | 1.36M | 1.36M | 1.1M |
Shares Outstanding (Diluted) | 8.95M | 8.7M | 8.7M | 8.7M | 8.7M | 6.17M | 5.67M | 3.77M | 1.36M | 1.36M | 1.36M | 1.36M | 1.36M | 1.36M | 1.36M | 1.36M | 1.36M | 1.1M |
EPS (Basic) | -2.58 | -2.15 | -2 | -1.65 | -0.45 | -1.73 | -4.33 | -6.91 | -9.26 | -10.79 | -11.11 | -10.67 | -17.95 | -17.65 | -18.53 | -15.97 | -12.19 | -16.73 |
EPS (Diluted) | -2.58 | -2.15 | -2 | -1.65 | -1.8 | -3.08 | -5.68 | -8.26 | -9.26 | -10.79 | -11.11 | -10.67 | -17.95 | -17.65 | -18.53 | -15.97 | -12.19 | -16.73 |
EBITDA | -24.56M | -20.93M | -18.23M | -13.35M | -10.63M | -8.86M | -7.69M | -9.41M | -7.64M | -10.65M | -13.75M | -13.12M | -16.25M | -15.81M | -15.94M | -16.57M | -17.78M | -17.6M |
EBIT | -24.2M | -20.93M | -18.23M | -13.35M | -10.63M | -9.75M | -11.24M | -13.13M | -13.25M | -15.38M | -15.85M | -15.06M | -16.32M | -15.91M | -16.04M | -16.66M | -17.88M | -17.7M |
Depreciation & Amortization | 4.00 | 4.00 | n/a | n/a | 2.67M | 3.91M | 5.33M | 6.27M | 4.5M | 3.27M | 2.73M | 1.81M | 927.71K | 951.47K | 93.42K | 92.24K | 97.33K | 100.59K |